Accessibility settings

This paper is in the following e-collection/theme issue:

Early Results in Infodemiology and Infoveillance (151) Quality/Credibility of eHealth Information and Trust Issues (924) Public (e)Health, Digital Epidemiology and Public Health Informatics (2212) Information Seeking, Information Needs (638) Obesity and Nutrition as Public Health Problem (572) Information Demand (58) Obesity (137)

Published on in Vol 9 (2025)

This is a member publication of

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/68792, first published .
Laptop screen displays 3D human body scan and health data graph

Quality Assessment of Medical Institutions’ Websites Regarding Prescription Drug Misuse of Glucagon-Like Peptide-1 Receptor Agonists by Off-Label Use for Weight Loss: Website Evaluation Study

Quality Assessment of Medical Institutions’ Websites Regarding Prescription Drug Misuse of Glucagon-Like Peptide-1 Receptor Agonists by Off-Label Use for Weight Loss: Website Evaluation Study

Authors of this article:

Rie Oyama1 Author Orcid Image ;   Tsuyoshi Okuhara1 Author Orcid Image ;   Emi Furukawa2 Author Orcid Image ;   Hiroko Okada1 Author Orcid Image ;   Takahiro Kiuchi1 Author Orcid Image
Article Authors Cited by (7) Tweetations (2) Metrics

Journals

  1. Tolchinsky Wisen G, Casasa A, Martinez Pérez M, Padrós i Selma J. Modelo y criterios de acreditación de Web Médica Acreditada: consolidación de 25 años de trayectoria. Medicina Clínica 2025;165(6):107141 View
  2. Tolchinsky Wisen G, Casasa A, Martinez Pérez M, Padrós i Selma J. Framework and accreditation criteria of Web Médica Acreditada: Consolidating 25 years of development. Medicina Clínica (English Edition) 2025;165(6):107141 View
  3. Kohari J, Okuhara T, Shirabe R. Comprehensiveness, quality, and readability of non-invasive prenatal testing information on Japanese medical institution websites. PEC Innovation 2026;8:100462 View
  4. Wilson A, Chamberlin S, Dabbs W, Heidel R, Grabeel K. Readability and understandability of online patient education on semaglutide. Health Informatics Journal 2026;32(1) View
  5. Nowak K, Łupina K, Kalisz A, Ilkiewicz Ł, Janczura J. GLP-1 Receptor Agonists: Therapeutic Potential and Emerging Concerns. Current Pharmacology Reports 2026;12(1) View
  6. Anatriello A, Liguori V, Pentella C, Zinzi A, Longo M, Caruso P, Maiorino M, Esposito K, Capuano A. Evaluation of the safety profile of glucagon-like peptide-1 receptor agonists: a focus on thyroid cancer-related adverse events by using the European pharmacovigilance database. Pharmacological Reports 2026 View
  7. Dudzińska K, Kaftan A, Plenikowski J, Kahsin A, Kacprzak S, Greluk A, Żuk J, Ciszewski W, Jurewicz A, Plenikowska Z. THE DARK SIDE OF GLP-1 ANALOGS: ADVERSE EFFECTS, LIMITATIONS, AND SAFETY CONCERNS. International Journal of Innovative Technologies in Social Science 2026;3(2(50)) View